I ntroduction: Most frequent mode of transmission of HCV today is with intravenous drug use. Former intravenous (IV) drug users present population group more exposed to HCV infection. Longer period of substance abuse, common syringe, more sexual partners (drug users) represent independent, statistically significant risk factors in this population. Diagnosis of HCV infection is based on history, epidemiological data, and clinical presentation, blood tests, histopatological and virology investigation. Hepagnost C is fast immunochromatography test for qualitative detection of HCV antibodies in blood, serum or plasma. Sensitivity of this test compared to EIA is >99% and relative specificity 98,6%. Material and methods: At Clinic for Infectious diseases (Hepatology Department) voluntary testing with Hepagnost C test was done for 22 former drug users. Results of this cross-sectional study are processed with SPSS program for Windows. Results: Most of the subjects were male (95,5%), average age of 33±3,5 years with average length of drug usage of 10 (7-12,5) years. All positive (9/22) were tested with EIA test and HCV infection was confirmed (9/9), therefore positive predictive value for Hepagnost C is 100%. We investigated relative risk (RR) with IV drug usage. Higher risk for infection (1,7 times) was among IV. drug users. Odds ratio was 2,4 (chance for HCV in iv. drug users group is 2,4 times higher). Common syringes increase relative risk for 4,5 times, and Odds ratio for infection 9 times. Conclusions: Hepagnost C test of high sensitivity and specificity showed 100% prediction. It is simple, inexpensive and comfortable test with results within 15 minutes. Demographic characteristics of tested persons as well as statistical results do not deviate significantly from results in available literature.
INTRODUCTION

Hepatitis C is a viral infection of the liver caused by hepatitis C virus (HCV).
HCV infection is asymptomatic in most patients, and it is difficult to recognize, and acute hepatitis C occurs mainly in the anicteric form (1) . Source of HCV infection is always a man with acute or chronic HCV infection. HCV is most frequently transmitted by intravenous (iv.) drug use, use of blood and blood products and organ transplants (2) . Ways of transferring to a large extent are determined by the risk groups exposed to HCV infection. Longer intravenous addiction, common syringes in prisons, was independent statistically significant factors in a group of 405 iv. drug users (3). HCV prevalence varies within different countries, regions and among different population groups within the region. It is considered that there are 40 000 infected patients in Bosnia and Herzegovina. Hepatitis C exists is diagnosed and treated (4) . There is a high risk of disease among users of intravenous drugs because they use a common syringe and the needle as well. Also drug addicts who take drugs by sniffing powder can transmit the virus through shared straws, if the mucosa is damaged and stained with blood that contains a large number of HCV-RNA copies (4). It is believed that for every registered addict, another seven unregistered addicts exists. This phenomenon occurs among other because of vulnerability of population of drug addicts and fear of stigmatization environment (6) . A good model for approach to treatment and rehabilitation of people with addiction problems are therapeutic communities. There the clients take distinctive roles and adhere to clear rules designed to encourage the transition process of their recovery (7) . The task of the therapeutic community is to maintain motivation that is a prerequisite for successful treatment (8) . The diagnosis of HCV infection is based on history, epidemiological surveys, clinical, haematological, biochemical, histopathological and virological findings (3) . One of the reliable rapid tests is immunochromatography test for detec-tion qualitative antibodies to HCV in blood, serum or plasma. The test area of the membrane is covered with recombinant HCV antigen. Sensitivity of this test compared to the EIA is> 99% and relative specificity of 98.6% (5).
MATERIAL AND METHODS
At the Clinic for Infectious Diseases, Clinical Center of Sarajevo University we tested 22 subjects. Subjects were volunteers from one of the therapeutic communities in the Canton of Sarajevo. All are former longtime drug abusers. In addition to basic history/epidemiological data, testing with HepaGnost C Rapid Test (Laboratory Equipment Manufacturer, Zagreb, HR) was performed. The procedure implies that 1-2 drops of blood, serum or plasma is instiled in circular hole. For the analysis of whole blood 1 drop of buffer shuld be added and wait for 10-15 minutes (Figure 1.) 
RESULTS
Results are presented by tables and diagrams. A negative test result: only the presence of control (C) lines is noted Males constituted the majority (95.5%) of the sample. Employment in this community is less than half (40.9%). Three patients (13.6%) cited promiscuity as a risk factor, of which one was HCV positive. The number of iv users is predominant (81.8%) and 63.6% of them used a common syringes. HepaGnost C rapid test was positive in 40.9% of respondents. In all positive samples, we performed the EIA test, and it was positive (9/9), therefore the positive predictive value of test is 100% EIA tests.
Our sample showed that differences in average age of length of addiction among HCV positive and HCV negative are not statistically significant p=0,168.
Prevalence of HCV infection in group of iv. users 8/18 (44%), while in the other route of administration is 1/4 (25%).
Relative risk for disease is quotient of probability that examinee from group of exposed (iv. users) has disease and probability that examinee from group of unexposed (other route of administration) has disease, RR=1,76. Relative risk indicates higher possibility of disease depending on exposure (metod of application). Odds ratio for disease represents quotient of two chances: chance to have disease in exposed group and chance to have disease in unexposed group OR=2,4. By using common utensils for drug application OR=4,07, a RR (Relative risk)= 9,3.
DISCUSSION
According to the UNICEF survey (UNICEF Bosnia and Herzegovina, 2007), among drug users in 2007 conducted in Sarajevo, Banja Luka and Zenica (n=780), about 95% of injecting drug users injected heroin in the previous month (9), in our sample 82% of the examinees were iv. users. Most were in group between 25-34 years (9) whereas in our study, the average age was 33 ± 3.5 years. Males accounted for 90% of the tested sample (9) in our sample is 95.5%. Approximately 80% of the examinees were unemployed (9) , while this percentage in our sample was 60%. A third of injecting drug users said that they shared syringes and utensils with other intravenous drug users (9) , while in our sample 14/22 (68%) examinees shared utensils. In study Chang et al. (10) conducted with 899 patients, prevalence of anti-HCV positive was 67.2% among intravenous drug users (IVDU), in our study prevalence is 44%. In the same study among non-intravenous drug users (non-IVDU), these authors found the prevalence of HCV 14.7%, in our study prevalence is 25%. In Bosnia and Herzegovina prevalence of HCV in this subgroup is between 35 and 40% (1, 4) .
Our study showed no statistically significant difference (p=0.168) in the length of drug dependency among HCV positive and HCV-negative drug abusers, which is in agreement with results of Chang et al. (10) . There is a high risk of disease among IVDU, because often the same syringes and needles are shared (4) . Among IVDU, the sharing of needles, syringes and/or other accessories associated with the narcotics appear to pose the greatest risk of HCV infection, which gives the odds ratio (OR) of 4.84 (95% CI 1.88 to 12.43 ) (11) . OR for HCV in group of iv. drug users in our study were 2.4 while the same increased to 4.07 in iv. drug users who use shared equipment (syringes, needles). HepaGnostC rapid test showed a high accuracy in comparison with EIA tests (5). In our study positive predictive value (PPV) was 9/9 (100%).
CONCLUSION
Due to high rates of HCV infection among drug addicts, the investigation of risky behaviour should be routine in such a group. HepaGnost C test is a reliable, simple, cheap and comfortable, with a result within 15 minutes. Testing (with survey) can be performed on remote locations, with very little cost.
